MiMedx - 53 Year Dividend History | MDXG
Historical dividend payout and yield for MiMedx (MDXG) since 1971. The current TTM dividend payout for MiMedx (MDXG) as of December 20, 2024 is $0.00. The current dividend yield for MiMedx as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.346B |
$0.321B |
|
MiMedx is an integrated developer, processor and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. `Innovations in Regenerative Biomaterials` is the framework behind their mission to give physicians products and tissues to help the body heal itself. Their biomaterial platform technologies include AmnioFix and EpiFix, their tissue technologies processed from human amniotic membrane that is derived from donated placentas. Through their donor program, a mother delivering via full-term Caesarean section birth can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. They process the human amniotic membrane utilizing their proprietary PURION Process, to produce a safe and effective implant.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
